US 11,794,018 B2
Implantable medical device for treating arrhythmias
Brad C. Tischendorf, Minneapolis, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Jan. 15, 2021, as Appl. No. 17/150,250.
Prior Publication US 2022/0226652 A1, Jul. 21, 2022
Int. Cl. A61N 1/362 (2006.01); A61B 5/363 (2021.01); A61N 1/05 (2006.01); A61K 31/7076 (2006.01); A61M 5/168 (2006.01)
CPC A61N 1/3629 (2017.08) [A61B 5/363 (2021.01); A61K 31/7076 (2013.01); A61M 5/16813 (2013.01); A61N 1/0568 (2013.01); A61M 2205/04 (2013.01); A61M 2205/054 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/50 (2013.01); A61M 2210/125 (2013.01); A61M 2230/06 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An implantable medical device comprising:
processing circuitry configured to detect an occurrence of an arrhythmia in a heart of a patient;
a reservoir containing one or more therapeutically useful doses of a drug for treating the arrhythmia; and
a valve operable to be opened in response to detection of the occurrence of the arrhythmia in the heart of the patient to release a therapeutically useful dose of the drug into the heart of the patient to treat arrhythmia of the heart;
wherein the implantable medical device is adapted for one of implantation wholly within a heart chamber of the heart of the patient or within a pulmonary artery of the patient.